Jeffrey A. Singer’s article, published by CATO Institute, reveals recent evidence of the reluctance of lawmakers to adhere to the science behind medication-based treatment for opioid use disorder (MOUD) across the country, correlating to rises in overdose death rates. This article is a critique on codified barriers implemented by policymakers, from restrictions in dosing within Medicare and Medicaid to the perpetuation of stigma that coincides with substance use disorders as a byproduct of refuting science. Singer’s critique is exposing a need for policymakers to face the facts, trust the science, and advocate for our communities.
To read the full article, click here.
